Applied Therapeutics Inc’s filing revealed that its Chief Financial Officer Funtleyder Leslie D. unloaded Company’s shares for reported $78880.0 on Aug 22 ’24. In the deal valued at $5.83 per share,13,530 shares were sold. As a result of this transaction, Funtleyder Leslie D. now holds 277,911 shares worth roughly $1.3 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Perfetti Riccardo sold 22,681 shares, generating $132,230 in total proceeds. Upon selling the shares at $5.83, the Chief Medical Officer now owns 986,853 shares.
Before that, Shendelman Shoshana sold 357,423 shares. Applied Therapeutics Inc shares valued at $2,208,874 were divested by the President and CEO at a price of $6.18 per share. As a result of the transaction, Shendelman Shoshana now holds 4,810,430 shares, worth roughly $22.56 million.
William Blair initiated its Applied Therapeutics Inc [APLT] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. Leerink Partners began covering APLT with “an Outperform” recommendation on February 22, 2024. Barclays revised its rating on January 04, 2022. It rated APLT as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of APLT
On Monday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock fall -4.09% to $4.69. Over the last five days, the stock has lost -18.58%. Applied Therapeutics Inc shares have risen nearly 40.00% since the year began. Nevertheless, the stocks have risen 168.00% over the past one year. While a 52-week high of $9.39 was reached on 02/28/24, a 52-week low of $1.68 was recorded on 01/08/24. SMA at 50 days reached $5.64, while 200 days put it at $4.67.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 4.50, which if violated will result in even more drops to 4.30. On the upside, there is a resistance level at 4.94. A further resistance level may holdings at 5.18. The Relative Strength Index (RSI) on the 14-day chart is 33.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.61%. Stochastics %K at 6.87% indicates the stock is a buying.
How much short interest is there in Applied Therapeutics Inc?
A steep rise in short interest was recorded in Applied Therapeutics Inc stocks on 2024-08-30, growing by 0.62 million shares to a total of 9.77 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 9.15 million shares. There was a rise of 6.3%, which implies that there is a positive sentiment for the stock.
